Prevention of REStinosis with Tranilast & its Outcomes (PRESTO) trial

Results: -> patients with diabetes mellitus type 2 had higher* rates of complications after percutaneous coronary intervention than non-diabetics a) death 2.1% vs 0.9% b) myocardial infarction 1.9% vs 1.2% c) revascularization of the target vessel 17.9% vs 12.8% * statistically significant

References

- Journal Watch 24(8):62, 2004 - Mathew V et al Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109:476, 2004 PMID: 14732749